OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside
Camille Van Laere, Michel Koole, Christophe M. Deroose, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1720-1743
Open Access | Times Cited: 17
Camille Van Laere, Michel Koole, Christophe M. Deroose, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1720-1743
Open Access | Times Cited: 17
Showing 17 citing articles:
Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly
Catherine H. Marshall, Emmanuel S. Antonarakis, Mrinal M. Patnaik
Blood Reviews (2025), pp. 101269-101269
Closed Access | Times Cited: 2
Catherine H. Marshall, Emmanuel S. Antonarakis, Mrinal M. Patnaik
Blood Reviews (2025), pp. 101269-101269
Closed Access | Times Cited: 2
161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer
Evangelia-Alexandra Salvanou, Adamantia Apostolopoulou, Stavros Xanthopoulos, et al.
Materials (2025) Vol. 18, Iss. 2, pp. 248-248
Open Access
Evangelia-Alexandra Salvanou, Adamantia Apostolopoulou, Stavros Xanthopoulos, et al.
Materials (2025) Vol. 18, Iss. 2, pp. 248-248
Open Access
Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177
František Trejtnar, Pavel Bárta, Ján Kozempel, et al.
Nuclear Medicine and Biology (2025) Vol. 144-145, pp. 108998-108998
Closed Access
František Trejtnar, Pavel Bárta, Ján Kozempel, et al.
Nuclear Medicine and Biology (2025) Vol. 144-145, pp. 108998-108998
Closed Access
Exploration of Synergic Solvent Extraction and Extraction Chromatographic Materials for the Separation of 161Tb from Enriched 160Gd Targets
Connor K. Holiski, Lauren Hoekstra, N.S.C. Becker, et al.
Journal of Chromatography A (2025) Vol. 1749, pp. 465869-465869
Closed Access
Connor K. Holiski, Lauren Hoekstra, N.S.C. Becker, et al.
Journal of Chromatography A (2025) Vol. 1749, pp. 465869-465869
Closed Access
The Advancement of Targeted Alpha Therapy and the Role of Click Chemistry Therein
Sara Lacerda, Robin M. de Kruijff, Kristina Djanashvili
Molecules (2025) Vol. 30, Iss. 6, pp. 1296-1296
Open Access
Sara Lacerda, Robin M. de Kruijff, Kristina Djanashvili
Molecules (2025) Vol. 30, Iss. 6, pp. 1296-1296
Open Access
Advances with radiopharmaceutical therapy in cancer
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy
B. Bogdanovič, Florent Hugonnet, Christopher Montemagno
Cancers (2025) Vol. 17, Iss. 7, pp. 1247-1247
Open Access
B. Bogdanovič, Florent Hugonnet, Christopher Montemagno
Cancers (2025) Vol. 17, Iss. 7, pp. 1247-1247
Open Access
Cytotoxicity Comparison of 99mTc-Labeled Peptide Antagonist and Agonist Targeting the SSTR2 Receptor in AR42J Cells
Sahar Nosrati Shanjani, Monika Łyczko, Rafał Walczak, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1715-1715
Open Access
Sahar Nosrati Shanjani, Monika Łyczko, Rafał Walczak, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1715-1715
Open Access
Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161
Joana F. Santos, Camille Van Laere, Catarina D. Silva, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
Joana F. Santos, Camille Van Laere, Catarina D. Silva, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development
Helena Koniar, Scott McNeil, Luke Wharton, et al.
EJNMMI Physics (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Helena Koniar, Scott McNeil, Luke Wharton, et al.
EJNMMI Physics (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies
Maskur, Hendris Wongso, Titis Sekar Humani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106104-106104
Closed Access | Times Cited: 2
Maskur, Hendris Wongso, Titis Sekar Humani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106104-106104
Closed Access | Times Cited: 2
The Production and Separation of 161Tb with High Specific Activity at the University of Utah
Connor K. Holiski, Aidan A Bender, Peñafrancia F Monte, et al.
Applied Radiation and Isotopes (2024) Vol. 214, pp. 111530-111530
Closed Access | Times Cited: 2
Connor K. Holiski, Aidan A Bender, Peñafrancia F Monte, et al.
Applied Radiation and Isotopes (2024) Vol. 214, pp. 111530-111530
Closed Access | Times Cited: 2
Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review
Ahmed Saad Abdlkadir, Florian Rosar, Amir Reza Jalilian, et al.
Nuclear Medicine and Molecular Imaging (2024) Vol. 59, Iss. 1, pp. 50-61
Closed Access | Times Cited: 2
Ahmed Saad Abdlkadir, Florian Rosar, Amir Reza Jalilian, et al.
Nuclear Medicine and Molecular Imaging (2024) Vol. 59, Iss. 1, pp. 50-61
Closed Access | Times Cited: 2
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
L. De Nardo, S. Santi, Anna Dalla Pietà, et al.
EJNMMI Physics (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
L. De Nardo, S. Santi, Anna Dalla Pietà, et al.
EJNMMI Physics (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Lanthanides and their complexes/nanoparticles: A review of cancer diagnosis, therapeutics, toxicity considerations, and clinical trials
Tatenda Madanhire, Louis‐Charl C. Coetzee, Adedapo S. Adeyinka, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106561-106561
Closed Access | Times Cited: 1
Tatenda Madanhire, Louis‐Charl C. Coetzee, Adedapo S. Adeyinka, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106561-106561
Closed Access | Times Cited: 1
Production and radiochemical separation of Tb-161 as a feasible beta therapeutic radioisotope from reactor irradiated Gd target
Mohamed A. Gizawy, Ahmed M. Shahr El-Din, Ε. H. Borai, et al.
Journal of Chromatography A (2024) Vol. 1737, pp. 465439-465439
Closed Access
Mohamed A. Gizawy, Ahmed M. Shahr El-Din, Ε. H. Borai, et al.
Journal of Chromatography A (2024) Vol. 1737, pp. 465439-465439
Closed Access
Proton-induced nuclear reactions on barium-136 for the production of the medically relevant radionuclide lanthanum-135
I.A. Khomenko, Е. С. Кормазева, Т. В. Богомолова, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 12
Closed Access
I.A. Khomenko, Е. С. Кормазева, Т. В. Богомолова, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 12
Closed Access
